Browse Category

Analyst Forecasts News 18 December 2025 - 19 December 2025

PepsiCo Stock (PEP) After the Bell Dec. 18, 2025: Key News, Analyst Forecasts, and What to Watch Before the Market Opens Friday

PepsiCo Stock (PEP) After the Bell Dec. 18, 2025: Key News, Analyst Forecasts, and What to Watch Before the Market Opens Friday

PepsiCo, Inc. (NASDAQ: PEP) finished Thursday’s session modestly lower even as the broader market rallied on softer-than-expected inflation data—leaving investors heading into Friday’s open focused on a familiar mix of catalysts: Wall Street’s latest price-target moves, PepsiCo’s newly outlined 2026
Linde plc (LIN) Stock After Hours Today (Dec. 18, 2025): News, Analyst Forecasts, and What to Watch Before Friday’s Open

Linde plc (LIN) Stock After Hours Today (Dec. 18, 2025): News, Analyst Forecasts, and What to Watch Before Friday’s Open

Linde plc (NASDAQ: LIN) finished Thursday’s session modestly lower and then went quiet in after-hours trading—an important setup as markets head into a potentially volatile Friday driven more by macro data and derivatives expiration than by fresh company-specific catalysts. As
Coinbase Stock (COIN) After Hours Today (Dec. 18, 2025): Key News, Analyst Forecasts, and What to Watch Before Friday’s Open

Coinbase Stock (COIN) After Hours Today (Dec. 18, 2025): Key News, Analyst Forecasts, and What to Watch Before Friday’s Open

Coinbase Global, Inc. (NASDAQ: COIN) is ending Thursday’s session with a familiar mix of big-picture ambition and near-term volatility—exactly the combination that has defined crypto-linked equities this year. COIN after-hours check: where Coinbase stock stands tonight After the closing bell
Eli Lilly Stock (LLY) After Hours Today (Dec. 18, 2025): Orforglipron Headlines, Analyst Forecasts, and What to Watch Before Friday’s Open

Eli Lilly Stock (LLY) After Hours Today (Dec. 18, 2025): Orforglipron Headlines, Analyst Forecasts, and What to Watch Before Friday’s Open

Eli Lilly and Company (NYSE: LLY) finished Thursday’s session higher and held those gains in after-hours trading, as investors digested fresh late-stage data for its oral obesity candidate orforglipron—and weighed a second, potentially market-moving theme: pricing pressure and affordability initiatives.
Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals (CRNX) Stock Drops After CMO Departure Filing: Latest News, Analyst Forecasts, and What’s Next (Dec. 18, 2025)

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stock slid sharply on Thursday, December 18, 2025, after a regulatory filing revealed a leadership transition involving the company’s Chief Medical and Development Officer. In trading, CRNX fell roughly 8% to around the mid‑$40s, with
1 18 19 20 21 22 43
Go toTop